Details for Patent: 9,855,335
✉ Email this page to a colleague
Which drugs does patent 9,855,335 protect, and when does it expire?
Patent 9,855,335 protects TIGECYCLINE and is included in one NDA.
This patent has eight patent family members in eight countries.
Summary for Patent: 9,855,335
| Title: | Tigecycline composition for injection |
| Abstract: | Disclosed is a tigecycline composition for injection, comprising the active component, tigecycline, and a propping agent. Also included is a stabilization agent. Also disclosed is a stable, pharmaceutically acceptable reconstitution liquid having freeze-dried tigecycline. The tigecycline composition for injection of the present invention has good redissolution, and can dissolve without intense shaking, thereby avoiding foams caused by intense shaking. Upon testing, the tigecycline composition and the tigecycline composition-diluted reconstitution liquid prepared in the present invention prove to have substantially lowered oxidation degradation and epimer generation and increased stability of the tigecycline preparation. Compared to the compositions currently in clinical use, the composition of the present invention can increase the treatment effect of tigecycline, avoid safety risks caused by lactose, is easy to produce and store, and has a clinical usage stability, satisfying the requirements for clinical medicine. |
| Inventor(s): | Quin; Jihong (Shanghai, CN) |
| Assignee: | GALENICUM HEALTH S.L. (Barcelona, ES) |
| Application Number: | 14/413,854 |
|
Patent Claim Types: see list of patent claims | Use; Composition; Formulation; |
Drugs Protected by US Patent 9,855,335
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Amneal | TIGECYCLINE | tigecycline | POWDER;INTRAVENOUS | 211158-001 | Aug 2, 2018 | AP | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
Foreign Priority and PCT Information for Patent: 9,855,335
| Foriegn Application Priority Data | ||
| Foreign Country | Foreign Patent Number | Foreign Patent Date |
| China | 2012 1 0078509 | Mar 22, 2012 |
| PCT Information | |||
| PCT Filed | April 07, 2013 | PCT Application Number: | PCT/CN2013/000397 |
| PCT Publication Date: | September 26, 2013 | PCT Publication Number: | WO2013/139179 |
International Family Members for US Patent 9,855,335
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Canada | 2879383 | ⤷ Try a Trial | |||
| China | 103315947 | ⤷ Try a Trial | |||
| European Patent Office | 2881109 | ⤷ Try a Trial | |||
| Spain | 2795421 | ⤷ Try a Trial | |||
| Poland | 2881109 | ⤷ Try a Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
